Gene-editing tool helps target small cancer-linked mutations

A new gene-editing tool created by Weill Cornell Medicine investigators will enable cancer researchers to study the impact of specific genetic changes in preclinical models.

COVID boosters show value for those pregnant or trying to conceive

Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.

Using broad race categories in medicine hides true health risks

Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.

Potential neuropathic pain treatment shows promise in preclinical tests

A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.

Throwing shade: Model maps NYC street trees’ cooling benefits

Tree Folio NYC creates a high-resolution “digital twin” of New York City’s urban canopy, simulating how local conditions influence shading that is important to mitigating climate change and heat island effects.

Hep C treatment initiation low among Medicaid recipients

Only one in five Medicaid enrollees diagnosed with hepatitis C virus started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.

Cornell introduces new AI-focused Board Governance program

Board Governance: Navigating Emerging Technologies and More in a Complex World, a new Cornell Tech immersion program, is set to prepare corporate board members for fast-paced evolutions driving the future of commerce.

Around Cornell

Sonnenberg receives NIH grant for IBD research

Weill Cornell Medicine associate professor Gregory F. Sonnenberg has been awarded a five-year, $3.26 million grant from the National Institutes of Health to investigate the underlying mechanisms of inflammatory bowel disease.

Study to compare heart procedure benefits in underrepresented groups

A multi-institution team led by a Weill Cornell Medicine scientist has been approved for $30 million in funding from the Patient-Centered Outcomes Research Institute to study heart procedure outcomes in underrepresented groups.